Prostate Intelligence™

Lucida Medical

Pi, Prostate Intelligence, is an AI and machine learning based software system designed to help radiologists detect and report the presence of prostate cancer lesions from MR scans (MRI). Pi is intended to augment a radiologist’s interpretation of prostate MRI by providing a risk score, prostate segmentation and aiding lesion identification and segmentation.

Product specifications

Information source: Vendor
Last updated: June 8, 2021

General
Product name	Prostate Intelligence™
Company	Lucida Medical
Subspeciality	Abdomen
Modality	MR
Disease targeted	Prostate cancer
Key-features	Prostate segmentation, AI-supported ROI segmentation, lesion risk score, PI-RADS v2.1 scoring support, structured report
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps)
Data characteristics
Population	Prostate MRI scans with suspicion of prostate cancer
Input	MRI, T2, DWI, DCE (optional)
Input format	DICOM
Output	Segmentation overlay, 3D vizualization, structured report with key images and risk score
Output format	DICOM
Technology
Integration	Integration in standard reading environment (PACS)
Deployment	Locally on dedicated hardware, Cloud-based
Trigger for analysis	Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time	1 - 10 minutes
Certification
CE	Certified, Class I , MDD
FDA	No or not yet
Market presence
On market since	05-2021
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model	Pay-per-use, Subscription
Based on	Number of analyses, Number of installations
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers